drugset
drugset / Trial / NCT03357276

Mix Vaccine for Metastatic Colorectal Cancer

NCT03357276 ↗

Phase 1/2 Completed 30 enrolled Fuda Cancer Hospital, Guangzhou Jinan University Guangzhou · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is the safety and efficacy of mix vaccine to small metastases of colorectal cancer.

Timeline

Start
2017-11-30
Primary completion
2018-11-30
Completion
2019-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Mix vaccine Vaccine 0.5 ml Subcutaneous

Indications

colorectal cancer